Genomenon

Genomic Evidence at the Gene and Variant Level

Ann Arbor, United States · Founded 2014 · $44.1M raised

Employees
51–200
Founded
2014
Business Model
B2B
Total Funding
$44.1M
Last Round
$5.5M Series BMay 2024
Rounds
9

About

Genomenon is an AI-powered genomic intelligence company that transforms biomedical literature into actionable variant insights for clinical diagnostics and precision medicine. Its Mastermind platform organizes evidence across 27 million genomic variants, helping over 250 clinical labs and 75 pharma programs accelerate rare disease diagnosis and drug development.

Summary

Genomenon is a Biotech company based in Ann Arbor, United States, founded in 2014. It has raised $44.1M in total across 9 rounds, most recently a $5.5M Series B round in May 2024. Investors include Beringea, Spring Mountain Capital and Michigan Angel Fund.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries BMay 2024
$5.5M

Sign up to see all 9 rounds

Seed through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Genomenon on Indexed.vc
<a href="https://indexed.vc/companies/genomenon"><img src="https://indexed.vc/api/badge/company/genomenon" alt="Genomenon on Indexed.vc" width="260" height="76" /></a>